2m 2m 2m 2m 2m 2m 2m
Syndax Pharmaceu (SNDX)
NASDAQ
$23.12+$0.22 (+0.98%)
Price as of Jul 13, 2026 6:18 PM EDT- $2.1BMarket Cap
- 132.39%1-Year Change
- BiotechnologyIndustry
Syndax Pharmaceu (SNDX)
$23.12+$0.22 (+0.98%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 124.8M +427.21% | 23.7M N/A | 0 -100.00% | 139.7M 0.00% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 124.8M +427.21% | 23.7M N/A | 0 -100.00% | 139.7M 0.00% | |
Sales and Marketing Expense | 179.7M +48.65% | 120.9M +80.63% | 66.9M N/A | N/A N/A | |
Research and Development Expense | -258.8M +7.09% | -241.6M +48.22% | -163.0M +37.58% | -118.5M +34.28% | |
Depreciation and Amortization Expense | 6.0M -25.00% | 8.0M -33.33% | 12.0M -63.64% | 33.0M +76,644.19% | |
Total Operating Expenses | 445.4M +22.59% | 363.4M +58.01% | 230.0M +51.53% | 151.8M +33.72% | |
Operating Profit | -273.1M -19.60% | -339.7M +47.71% | -230.0M +51.53% | -151.8M -678.78% | |
Interest Income | 22.7M -12.88% | 26.1M +23.28% | 21.2M +260.41% | 5.9M +1,357.07% | |
Interest Expense | -33.8M +576.00% | -5.0M +2,303.85% | -208,000 -93.37% | -3.1M +65.19% | |
Interest Income and Expense and Net | -11.1M -152.49% | 21.1M +0.64% | 21.0M +666.18% | 2.7M +282.82% | |
Total Nonoperating Income and Expense | -12.3M -158.99% | 20.9M +1.55% | 20.6M +751.34% | 2.4M +286.94% | |
Income before Taxes | -285.4M -10.46% | -318.8M +52.25% | -209.4M +40.19% | -149.3M -699.13% | |
Income Taxes | 433,000 N/A | N/A N/A | N/A N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -285.4M -10.46% | -318.8M +52.25% | -209.4M +40.19% | -149.3M -699.13% | |
Net Income from Continuing Operations Applicable to Common | -285.4M -10.46% | -318.8M +52.25% | -209.4M +40.19% | -149.3M -699.13% | |
Basic EPS and Net Income | -3.29 -11.56% | -3.72 +24.83% | -2.98 +21.14% | -2.46 -612.50% | |
Diluted EPS and Net Income | -3.29 -11.56% | -3.72 +24.83% | -2.98 +21.14% | -2.46 -634.78% | |
Basic Weighted Average Shares | 86.6M +1.17% | 85.6M +21.67% | 70.4M +15.82% | 60.8M +16.70% | |
Diluted Weighted Average Shares | 86.6M +1.17% | 85.6M +21.67% | 70.4M +15.82% | 60.8M +13.31% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 134.9M -12.43% | 154.1M -47.84% | 295.4M +297.27% | 74.4M -66.50% | |
Short-Term Investments | 259.1M -38.12% | 418.8M +52.12% | 275.3M -31.42% | 401.4M +84.17% | |
Cash and Cash Equivalents and Short-Term Investments | 394.1M -31.21% | 572.9M +0.38% | 570.7M +19.94% | 475.8M +8.15% | |
Total Current Assets | 528.1M -12.43% | 603.1M +3.82% | 580.9M +18.60% | 489.8M +9.23% | |
Accumulated Depreciation | 425,000 +1.43% | 419,000 +1.95% | 411,000 +3.01% | 399,000 -9.93% | |
Property and Plant and Equipment and Net | 181,000 N/A | 0 -100.00% | 8,000 -60.00% | 20,000 -92.81% | |
Total Long-Term Assets | 181,000 N/A | 0 -100.00% | 463,000 -42.63% | 807,000 -36.31% | |
Total Assets | 529.7M -26.92% | 724.8M +18.26% | 612.9M +23.26% | 497.2M +10.58% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 0 -100.00% | 12.1M N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 120.1M +16.00% | 103.5M +78.24% | 58.1M +99.88% | 29.1M +40.53% | |
Total Long-Term Debt | N/A N/A | 331.6M N/A | N/A N/A | 0 -100.00% | |
Total Long-Term Liabilities | 345.0M +3.55% | 333.1M +56,556.97% | 588,000 -18.56% | 722,000 -96.50% | |
Total Liabilities | 465.1M +6.50% | 436.7M +644.14% | 58.7M +97.01% | 29.8M -27.86% | |
Retained Earnings | -1.5B +23.37% | -1.2B +35.32% | -902.4M +30.21% | -693.0M +27.47% | |
Total Stockholders Equity | 64.6M -77.57% | 288.1M -48.01% | 554.2M +18.56% | 467.4M +14.47% | |
Total Shares Outstanding | 87.4M +2.00% | 85.7M +1.02% | 84.8M +24.54% | 68.1M +23.88% | |
Cash Flow | |||||
Cash from Operating Activities | -323.0M +17.49% | -274.9M +71.17% | -160.6M +20.14% | -133.7M -558.88% | |
Capital Expenditures | 187,000 N/A | N/A N/A | 0 N/A | 0 -100.00% | |
Cash from Investing Activities | 290.0M +231.97% | -219.8M -286.87% | 117.6M +163.17% | -186.2M +355.53% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 13.7M -96.13% | 353.4M +33.78% | 264.1M +53.34% | 172.3M +45.41% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -218.74% -84.75% | -1,434.43% N/A | N/A N/A | -108.62% -678.78% | |
Return on Assets | -45.50% -4.52% | -47.66% +26.35% | -37.72% +19.58% | -31.54% -574.72% | |
Return on Equity | -161.82% +113.81% | -75.69% +84.67% | -40.98% +20.18% | -34.10% -551.87% | |
Revenue Growth | 427.21% N/A | N/A N/A | -100.00% N/A | 0.00% -100.00% | |
Current Ratio | 4.40 -24.51% | 5.82 -41.75% | 10.00 -40.67% | 16.85 -22.27% | |
Cash Ratio | 1.12 -24.51% | 1.49 -70.74% | 5.08 +98.75% | 2.56 -76.16% | |
Debt-to-Equity Ratio | N/A N/A | 1.19 N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | 0.47 N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow